sales@businessmarketinsights.com     UK: +442081254005
   

Asia Pacific Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)), Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and Geography

Code: TIPRE00014186 | Pages: 115 | Industry: Pharmaceuticals | Date: Sep 2020
Covid

Market Introduction

Allergen immunotherapy, also known as hypo-sensitization or desensitization, is a medical treatment for allergies. Measured doses of allergens are given to the patient resulting in reduced inflammation, which causes immune system to become less sensitive to the substance by blocking antibody function. Allergy immunotherapy primary therapeutic goals include reducing symptoms, reducing symptomatic medication use, and improving allergy-related quality of life.

Market Overview and Dynamics

The Asia-Pacific allergy Immunotherapies Market was valued at US$ 365.47 million in 2019 and is projected to reach US$ 871.08 million by 2027; it is expected to grow at a CAGR of 11.5% during the forecast period. Asia-Pacific is expected to witness substantial growth over the years owing to increasing chronic diseases, increasing disposable income in the region, improving healthcare infrastructure and others. However, drawbacks associated with the use of allergy immunotherapies and regulatory variations across regions are likely to hamper the growth of the market during the forecast period.

 

Key Market Segments

The Asia Pacific allergy immunotherapies market, based on treatment, the SCIT segment held a larger share of the market in 2019. However, the SLIT segment is expected to register a higher CAGR in the market during the forecast period. The Asia Pacific allergy immunotherapies market, based on allergy type, the allergic rhinitis segment held the largest share of the market in 2019 and is anticipated to grow at a significant CAGR during forecast period. In 2019, the hospital pharmacy segment held the largest share of the market. Based on distribution channel, the hospital pharmacy segment held the largest share of the market in 2019 and is expected to register a higher CAGR in the market during the forecast period.

 

Major Sources and Companies Listed

Some of the major primary and secondary sources for automated compounding systems market included in the report are Celsion Corporation, World Allergy Organization (WAO) and Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAACI)

 

 

 

 

 

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of the Asia Pacific allergy immunotherapy market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the allergy immunotherapy market, providing a clear picture of future opportunities that will help Analyse, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific immunotherapy market.

 

 

 

ASIA PACIFIC ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION

Asia Pacific Allergy Immunotherapies Market – By Treatment

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

Asia Pacific Allergy Immunotherapies Market – By Allergy Type

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others

Asia Pacific Allergy Immunotherapies Market – By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Asia Pacific Allergy Immunotherapies Market – By Country

  • China
  • Japan
  • India
  • Australia
  • South Korea

 

Company Profiles

  • HAL Allergy B.V.
  • ALK Abello A/S
  • Stallergenes Greer
  • Anergis
  • Circassia

TABLE OF CONTENTS

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1      Asia Pacific Allergy Immunotherapies Market – By Treatment

1.3.2      Asia Pacific Allergy Immunotherapies Market – By Allergy Type

1.3.3      Asia Pacific Allergy Immunotherapies Market – By Distribution Channel

1.3.4      Asia Pacific Allergy Immunotherapies Market – By Geography

2.          Asia Pacific Allergy Immunotherapies Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Allergy Immunotherapies Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1      Asia-Pacific – PEST Analysis

4.3        Expert Opinion

5.          Asia Pacific Allergy immunotherapies Market – Key Market Dynamics

5.1        Key Market Drivers

5.1.1      Growing Prevalence of Allergic Disorders

5.1.2      Technological Advancements in Sublingual Dosage Formulations

5.2        Key Market Restraint

5.2.1      Drawbacks Associated with the Use of Allergy Immunotherapy

5.2.2      Regulatory Variations Across Regions

5.3        Key Market Opportunities

5.3.1      Expansion of Pharmacy across Globe

5.4        Future Trends

5.4.1      Increasing Research and Development for Drugs

5.5        Impact Analysis

6.          Allergy Immunotherapies Market – Asia Pacific Analysis

6.1.1      Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)

7.          Asia Pacific Allergy Immunotherapies Market Analysis– by Treatment

7.1        Overview

7.2        Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)

7.3        Subcutaneous Immunotherapy (SCIT)

7.3.1      Overview

7.4        Sublingual Immunotherapy (SLIT)

7.4.1      Overview

7.4.2      Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

8.          Allergy Immunotherapies Market Analysis– by Allergy Type

8.1        Overview

8.2        Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)

8.3        Allergic Rhinitis

8.3.1      Overview

8.3.2      Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)

8.4        Asthma

8.4.1      Overview

8.4.2      Asthma Market Revenue and Forecasts to 2027 (US$ Million)

8.5        Food Allergy

8.5.1      Overview

8.5.2      Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)

8.6        Venom Allergy

8.6.1      Overview

8.6.2      Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)

8.7        Other Allergies

8.7.1      Overview

8.7.2      Others Market Revenue and Forecasts to 2027 (US$ Million)

9.          Allergy Immunotherapies Market Analysis– by Distribution Channel

9.1        Overview

9.2        Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)

9.3        Hospital Pharmacy

9.3.1      Overview

9.3.2      Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

9.4        Retail Pharmacy

9.4.1      Overview

9.4.2      Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

9.5        Online Pharmacy

9.5.1      Overview

9.5.2      Online PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

10.       Allergy Immunotherapies Market Analysis And Forecasts To 2027 – Geographical Analysis

10.1 Asia-Pacific: Allergy Immunotherapies Market

10.1.1   Overview

10.1.2   Asia-Pacific: Allergy Immunotherapies Market - Revenue and Forecast to 2027 (USD Million)

10.1.3   Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.4   Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.5   Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6   Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)

10.1.7   China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.8   Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.9   India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.10 South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1    South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2    South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.10.3    South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.10.4    South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.11 Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1    Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2    Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.11.3    Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.11.4    Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.       Impact of COVID-19 Pandemic on Asia Pacific Allergy Immunotherapies Market

11.1     Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.       Company Profiles

12.1     ALK-Abelló A/S

12.1.1   Key Facts

12.1.2   Business Description

12.1.3   Products and Services

12.1.4   Financial Overview

12.1.5   SWOT Analysis

12.1.6   Key Developments

12.2     Stallergenes Greer

12.2.1   Key Facts

12.2.2   Business Description

12.2.3   Products and Services

12.2.4   Financial Overview

12.2.5   SWOT Analysis

12.2.6   Key Developments

12.3     HAL Allergy B.V.

12.3.1   Key Facts

12.3.2   Business Description

12.3.3   Products and Services

12.3.4   Financial Overview

12.3.5   SWOT Analysis

12.3.6   Key Developments

12.4     Johnson and Johnson Services, Inc.

12.4.1   Key Facts

12.4.2   Business Description

12.4.3   Products and Services

12.4.4   Financial Overview

12.4.5   SWOT Analysis

12.4.6   Key Developments

12.5     Anergis

12.5.1   Key Facts

12.5.2   Business Description

12.5.3   Products and Services

12.5.4   Financial Overview

12.5.5   SWOT Analysis

12.5.6   Key Developments

12.6     DBV Technologies

12.6.1   Key Facts

12.6.2   Business Description

12.6.3   Products and Services

12.6.4   Financial Overview

12.6.5   SWOT Analysis

12.6.6   Key Developments

12.7     Allergy Therapeutics

12.7.1   Key Facts

12.7.2   Business Description

12.7.3   Products and Services

12.7.4   Financial Overview

12.7.5   SWOT Analysis

12.7.6   Key Developments

13.       Appendix

13.1     Glossary of Terms

 


LIST OF TABLES

Table 1.            Asia-Pacific Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 2.            Asia-Pacific Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 3.            Asia-Pacific Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 4.            China Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 5.            China Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            China Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.            Japan Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 8.            Japan Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 9.            Japan Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 10.         India Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 11.         India Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 12.         India Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.         South Korea Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14.         South Korea Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 15.         South Korea Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 16.         Australia Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 17.         Australia Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 18.         Australia Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 19.         Glossary of Terms, Allergy Immunotherapies Market

 


LIST OF FIGURES

Figure 1.          Allergy Immunotherapies Market Segmentation

Figure 2.          Asia Pacific Allergy Immunotherapies Market Overview

Figure 3.          Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market

Figure 4.          Asia-Pacific to Show Remarkable Growth During Forecast Period

Figure 6.          Global Allergy Immunotherapies Market- Leading Country Markets (US$ Million)

Figure 7.          Asia-Pacific PEST Analysis

Figure 8.          Allergy immunotherapies Market Impact Analysis of Driver and Restraints

Figure 9.          Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)

Figure 10.        Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)

Figure 11.        Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 12.        Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 13.        Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)

Figure 14.        Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)

Figure 15.        Asthma Market Revenue and Forecasts to 2027 (US$ Million)

Figure 16.        Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 17.        Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 18.        Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 19.        Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)

Figure 20.        Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 21.        Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

Figure 22.        Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 23.        Asia-Pacific: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)

Figure 24.        Asia-Pacific Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)

Figure 25.        Asia-Pacific: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)

Figure 26.        China: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        Japan: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        India: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        South Korea: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Australia: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Impact of COVID-19 Pandemic on allergy immunotherapies market in Asia Pacific Countries

  1. HAL Allergy B.V.
  2. ALK Abello A/S
  3. Stallergenes Greer
  4. Anergis
  5. Circassia
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific allergy immunotherapies market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific allergy immunotherapies market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Related Tags Asia Pacific Allergy Immunotherapies Market Asia Pacific Allergy Immunotherapies Market Research Asia Pacific Allergy Immunotherapies Market Insight Asia Pacific Allergy Immunotherapies Market Trends Asia Pacific Allergy Immunotherapies Market Forecast Asia Pacific Allergy Immunotherapies Market Share Asia Pacific Allergy Immunotherapies Market 2027 Asia Pacific Allergy Immunotherapies Market Growth Asia Pacific Allergy Immunotherapies Industry Sector Asia Pacific Allergy Immunotherapies PDF Report Asia Pacific Allergy Immunotherapies Analysis Asia Pacific Allergy Immunotherapies Research Competitive Analysis

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000